Earnings Surge Sparks Debate: Synopsys delivered first-quarter revenue of $2.41 billion, up 65% year-over-year and hitting the top of guidance, fueling social media chatter on its robust demand for chip design tools. While non-GAAP earnings beat estimates, a GAAP net loss from Ansys acquisition costs and 10% workforce cuts raised flags about integration hurdles.
Nvidia CEO Bolsters Confidence: Nvidia's Jensen Huang defended software firms like Synopsys on CNBC, arguing the market misjudges AI's impact on their essential role in complex chip development. Social media users highlighted this as a vote of confidence amid premarket volatility.
Analyst Caution Persists: Discussions also touched on HSBC's downgrade to Hold, citing geopolitical risks and muted IP growth, tempering optimism despite a new $2 billion buyback. Overall, traders weigh Synopsys's AI tailwinds against near-term uncertainties.
Note: This discussion summary was generated from an AI condensation of post data.
Synopsys Insider Trading Activity
Synopsys insiders have traded $SNPS stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $SNPS stock by insiders over the last 6 months:
- SUDHINDRA KANKANWADI (Chief Accounting Officer) has made 0 purchases and 2 sales selling 15,873 shares for an estimated $7,837,408.
- SASSINE GHAZI (PRESIDENT AND CEO) sold 11,366 shares for an estimated $6,694,725
- SHELAGH GLASER (CFO) has made 0 purchases and 4 sales selling 7,312 shares for an estimated $3,913,745.
- JANET LEE (GC & Corporate Secretary) has made 0 purchases and 2 sales selling 500 shares for an estimated $260,000.
- ROBERT G PAINTER purchased 350 shares for an estimated $148,903
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Synopsys Revenue
Synopsys had revenues of $2.4B in Q1 2026. This is an increase of 65.52% from the same period in the prior year.
You can track SNPS financials on Quiver Quantitative's SNPS stock page.
Synopsys Congressional Stock Trading
Members of Congress have traded $SNPS stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $SNPS stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAN NEWHOUSE purchased up to $15,000 on 12/31.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 11/18, 10/09.
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Synopsys Hedge Fund Activity
We have seen 568 institutional investors add shares of Synopsys stock to their portfolio, and 949 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 5,443,736 shares (-73.6%) from their portfolio in Q4 2025, for an estimated $2,557,031,673
- NVIDIA CORP added 4,821,717 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,264,856,909
- FMR LLC added 1,687,848 shares (+29.1%) to their portfolio in Q4 2025, for an estimated $792,815,962
- PICTET ASSET MANAGEMENT HOLDING SA removed 1,332,153 shares (-56.7%) from their portfolio in Q4 2025, for an estimated $625,738,907
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,106,267 shares (-33.3%) from their portfolio in Q4 2025, for an estimated $519,635,735
- EDGEWOOD MANAGEMENT LLC removed 1,074,807 shares (-29.0%) from their portfolio in Q4 2025, for an estimated $504,858,344
- WELLINGTON MANAGEMENT GROUP LLP removed 1,066,539 shares (-51.6%) from their portfolio in Q4 2025, for an estimated $500,974,699
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Synopsys Government Contracts
We have seen $342,606 of award payments to $SNPS over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PURCHASE SOFTWARE FOR TCAD FABRICATION PROCESS SIMULATION: $110,100
- SYNPLIFY BASE PERPETUAL MAINTENANCE: $43,940
- SYNOPSYS SYNPLIFY SOFTWARE LICENSE: $33,800
- .1. THE PURPOSE OF ORDER W56JSR-23-P-0009 IS TO PROVIDE SUBSCRIPTION FIRM-FIXED-PRICE (FFP) SYNOPSIS SYNP...: $33,420
- SYNOPSYS SOFTWARE RENEWALS: $28,088
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Synopsys Analyst Ratings
Wall Street analysts have issued reports on $SNPS in the last several months. We have seen 10 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 12/11/2025
- Rosenblatt issued a "Buy" rating on 12/11/2025
- Citigroup issued a "Buy" rating on 11/24/2025
- Exane BNP Paribas issued a "Underperform" rating on 10/02/2025
- Mizuho issued a "Outperform" rating on 09/11/2025
- Morgan Stanley issued a "Overweight" rating on 09/11/2025
- Goldman Sachs issued a "Buy" rating on 09/10/2025
To track analyst ratings and price targets for Synopsys, check out Quiver Quantitative's $SNPS forecast page.
Synopsys Price Targets
Multiple analysts have issued price targets for $SNPS recently. We have seen 14 analysts offer price targets for $SNPS in the last 6 months, with a median target of $560.0.
Here are some recent targets:
- Clarke Jeffries from Piper Sandler set a target price of $430.0 on 02/26/2026
- Blair Abernethy from Rosenblatt set a target price of $560.0 on 02/20/2026
- Lee Simpson from Morgan Stanley set a target price of $550.0 on 12/12/2025
- Harlan Sur from JP Morgan set a target price of $650.0 on 12/11/2025
- Jason Celino from Keybanc set a target price of $600.0 on 12/11/2025
- Vivek Arya from B of A Securities set a target price of $560.0 on 12/11/2025
- Joe Quatrochi from Wells Fargo set a target price of $500.0 on 12/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
